01 1Piramal Pharma Solutions
01 1DILTIAZEM HYDROCHLORIDE USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-06
Pay. Date : 2013-01-31
DMF Number : 14713
Submission : 2000-01-27
Status : Active
Type : II
20
Piramal Pharma Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Piramal's expertise across varied technologies makes them a partner of choice for innovators & generic companies worldwide.
One of their notable products is DILTIAZEM HYDROCHLORIDE USP, with a corresponding US DMF Number 14713.
Remarkably, this DMF maintains an Active status since its submission on January 27, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 06, 2013, and payment made on January 31, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
